| # | Title | Journal | Year | Citations |
|---|
| 1 | An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies | Cannabis and Cannabinoid Research | 2017 | 413 |
| 2 | A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy | Cannabis and Cannabinoid Research | 2016 | 230 |
| 3 | Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users | Cannabis and Cannabinoid Research | 2016 | 203 |
| 4 | Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy | Cannabis and Cannabinoid Research | 2016 | 200 |
| 5 | A Cross-Sectional Study of Cannabidiol Users | Cannabis and Cannabinoid Research | 2018 | 192 |
| 6 | Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report | Cannabis and Cannabinoid Research | 2017 | 183 |
| 7 | Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry | Cannabis and Cannabinoid Research | 2016 | 173 |
| 8 | Cannabis and Pain: A Clinical Review | Cannabis and Cannabinoid Research | 2017 | 172 |
| 9 | Cannabinoid CB1and CB2Receptor Signaling and Bias | Cannabis and Cannabinoid Research | 2017 | 165 |
| 10 | CannabisSystematics at the Levels of Family, Genus, and Species | Cannabis and Cannabinoid Research | 2018 | 164 |
| 11 | Immune Responses Regulated by Cannabidiol | Cannabis and Cannabinoid Research | 2020 | 163 |
| 12 | Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification | Cannabis and Cannabinoid Research | 2016 | 142 |
| 13 | An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors | Cannabis and Cannabinoid Research | 2017 | 134 |
| 14 | Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes | Cannabis and Cannabinoid Research | 2016 | 119 |
| 15 | Emerging Evidence for Cannabis' Role in Opioid Use Disorder | Cannabis and Cannabinoid Research | 2018 | 116 |
| 16 | Endocannabinoids in the Gut | Cannabis and Cannabinoid Research | 2016 | 115 |
| 17 | TheCannabis sativaVersusCannabis indicaDebate: An Interview with Ethan Russo, MD | Cannabis and Cannabinoid Research | 2016 | 99 |
| 18 | Chronic Adolescent Δ9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment | Cannabis and Cannabinoid Research | 2017 | 99 |
| 19 | A Review of Hemp as Food and Nutritional Supplement | Cannabis and Cannabinoid Research | 2021 | 98 |
| 20 | Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial | Cannabis and Cannabinoid Research | 2018 | 93 |
| 21 | Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid | Cannabis and Cannabinoid Research | 2016 | 84 |
| 22 | Absence of Entourage: Terpenoids Commonly Found inCannabis sativaDo Not Modulate the Functional Activity of Δ9-THC at Human CB1and CB2Receptors | Cannabis and Cannabinoid Research | 2019 | 84 |
| 23 | Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment | Cannabis and Cannabinoid Research | 2016 | 81 |
| 24 | Training and Practices of Cannabis Dispensary Staff | Cannabis and Cannabinoid Research | 2016 | 75 |
| 25 | Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A | Cannabis and Cannabinoid Research | 2016 | 73 |
| 26 | Regulatory Status of Cannabidiol in the United States: A Perspective | Cannabis and Cannabinoid Research | 2018 | 72 |
| 27 | Cannabinoids in Parkinson's Disease | Cannabis and Cannabinoid Research | 2017 | 71 |
| 28 | The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation | Cannabis and Cannabinoid Research | 2018 | 71 |
| 29 | Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review | Cannabis and Cannabinoid Research | 2016 | 69 |
| 30 | The Anti-Inflammatory Properties of Terpenoids from Cannabis | Cannabis and Cannabinoid Research | 2018 | 69 |
| 31 | Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA | Cannabis and Cannabinoid Research | 2020 | 69 |
| 32 | Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts | Cannabis and Cannabinoid Research | 2017 | 68 |
| 33 | Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain | Cannabis and Cannabinoid Research | 2017 | 67 |
| 34 | Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression | Cannabis and Cannabinoid Research | 2018 | 60 |
| 35 | The Name ofCannabis: A Short Guide for Nonbotanists | Cannabis and Cannabinoid Research | 2016 | 59 |
| 36 | New York Physicians' Perspectives and Knowledge of the State Medical Marijuana Program | Cannabis and Cannabinoid Research | 2018 | 59 |
| 37 | Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9- Tetrahydrocannabinol-ProducingCannabis sativaL. Cultivars | Cannabis and Cannabinoid Research | 2017 | 58 |
| 38 | Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users | Cannabis and Cannabinoid Research | 2018 | 58 |
| 39 | Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form | Cannabis and Cannabinoid Research | 2016 | 54 |
| 40 | Theoretical Explanation for Reduced Body Mass Index and Obesity Rates in Cannabis Users | Cannabis and Cannabinoid Research | 2018 | 52 |
| 41 | The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies | Cannabis and Cannabinoid Research | 2021 | 52 |
| 42 | A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes | Cannabis and Cannabinoid Research | 2018 | 51 |
| 43 | Use and Perceptions of Cannabidiol Products in Canada and in the United States | Cannabis and Cannabinoid Research | 2022 | 50 |
| 44 | A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans | Cannabis and Cannabinoid Research | 2017 | 47 |
| 45 | Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two | Cannabis and Cannabinoid Research | 2017 | 47 |
| 46 | An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom | Cannabis and Cannabinoid Research | 2022 | 47 |
| 47 | Endocannabinoids and Immunity | Cannabis and Cannabinoid Research | 2016 | 46 |
| 48 | Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing | Cannabis and Cannabinoid Research | 2017 | 44 |
| 49 | Even High Doses of Oral Cannabidiol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102–112; DOI: 10.1089/can.2015.0004 | Cannabis and Cannabinoid Research | 2017 | 44 |
| 50 | Extractions of Medical Cannabis Cultivars and the Role of Decarboxylation in Optimal Receptor Responses | Cannabis and Cannabinoid Research | 2019 | 44 |
